Home  |  Contact

Cellosaurus OUMS-24F (CVCL_B370)

Cell line name OUMS-24F
Synonyms OUMS24F
Accession CVCL_B370
Resource Identification Initiative To cite this cell line use: OUMS-24F (RRID:CVCL_B370)
Comments Population: Japanese.
Doubling time: 62.8 +- 8.99 hours (Note=In 1% FBS), 39.7 +- 1.98 hours (Note=In 10% FBS) (PubMed=8428798).
Transformant: ChEBI; CHEBI:16907; 4-nitroquinoline N-oxide (4NQO).
Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
Cell type: Fibroblast; CL=CL_0000057.
Sequence variations
  • Mutation; HGNC; 11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (PubMed=8790940).
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_B369 (OUMS-24)
Children:
CVCL_WH83 (OUMS-24F/p53)CVCL_WH82 (OUMS-24F/RAS)
Sex of cell Female
Age at sampling 6FW
Category Transformed cell line
Publications

DOI=10.11418/jtca1981.12.4_313
Namba M., Bai L., Kano Y., Sugihara S., Miyazaki M.
Multistep malignant transformation of human cells: immortalization of human fibroblasts by treatment with 60Co gamma rays and 4-nitroquinoline 1-oxide, and their malignant transformation with the ras oncogene.
Tissue Cult. Res. Commun. 12:313-318(1993)

PubMed=8148305
Namba M., Iijima M., Kondo T., Jahan I., Mihara K.
Immortalization of normal human cells is a multistep process and a rate limiting step of neoplastic transformation of the cells.
Hum. Cell 6:253-259(1993)

PubMed=8428798; DOI=10.1002/ijc.2910530317
Bai L., Mihara K., Kondo Y., Honma M., Namba M.
Immortalization of normal human fibroblasts by treatment with 4-nitroquinoline 1-oxide.
Int. J. Cancer 53:451-456(1993)

PubMed=8557247; DOI=10.1007/BF00218823
Sugihara S., Mihara K., Marunouchi T., Inoue H., Namba M.
Telomere elongation observed in immortalized human fibroblasts by treatment with 60Co gamma rays or 4-nitroquinoline 1-oxide.
Hum. Genet. 97:1-6(1996)

PubMed=8744932; DOI=10.18926/AMO/30489
Iijima M., Kano Y., Nohno T., Namba M.
Cloning of cDNA with possible transcription factor activity at the G1-S phase transition in human fibroblast cell lines.
Acta Med. Okayama 50:73-77(1996)

PubMed=8790940; DOI=10.1247/csf.21.111
Mihara K., Iijima M., Kondo T., Namba M.
Selective expression of mutated p53 in human cells immortalized with either 4-nitroquinoline 1-oxide or 60Co gamma rays.
Cell Struct. Funct. 21:111-116(1996)

DOI=10.11418/jtca1981.16.3_173
Mihara K., Miyazaki M., Fushimi K., Tsuji T., Inoue Y., Fukaya K.-i., Ohashi R., Namba M.
The p53 gene status and other cellular characteristics of human cell lines maintained in our laboratory.
Tissue Cult. Res. Commun. 16:173-178(1997)

PubMed=9290701; DOI=10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D
Jia L.-Q., Osada M., Ishioka C., Gamo M., Ikawa S., Suzuki T., Shimodaira H., Niitani T., Kudo T., Akiyama M., Kimura N., Matsuo M., Mizusawa H., Tanaka N., Koyama H., Namba M., Kanamaru R., Kuroki T.
Screening the p53 status of human cell lines using a yeast functional assay.
Mol. Carcinog. 19:243-253(1997)

PubMed=9359923; DOI=10.18926/AMO/30789
Mihara K., Miyazaki M., Kondo T., Fushimi K., Tsuji T., Inoue Y., Fukaya K.-i., Ishioka C., Namba M.
Yeast functional assay of the p53 gene status in human cell lines maintained in our laboratory.
Acta Med. Okayama 51:261-265(1997)

Cross-references
Encyclopedic resources Wikidata; Q54936774
Polymorphism and mutation databases IARC_TP53; 5359
Entry history
Entry creation06-Jun-2012
Last entry update29-Jun-2023
Version number17